Galactocerebrosidase (GALC) is deficient in all tissues from human patients and animal models with globoid cell leukodystrophy (GLD) or Krabbe disease. The deficiency results in decreased lysosomal catabolism of certain galactolipids including galactosylceramide and psychosine that are synthesized maximally during myelination. According to current theories, the accumulation of psychosine in humans and animals with GLD induces oligodendrocyte degeneration and myelination ceases. Transduction of oligodendrocytes from twitcher mice with a retroviral vector containing the GALC cDNA can correct the enzyme deficiency in these cells. Our data show that twitcher astrocytes and oligodendrocytes can internalize exogenous GALC, as well as donate the enzyme to the mutant glial cells. Antibodies against human GALC localized the GALC antigen in retrovirally transduced cells and cells receiving enzyme via cell to cell secretion and uptake to the lysosomal fraction. In fact immunocytochemical studies in transduced oligodendrocytes revealed that the GALC colocalizes in vesicles lysosomal-associated membrane protein-2 (LAMP2) (؉). Moreover, labeling cells with anti-GALC and a marker for oligodendrocytes demonstrated that, upon differentiation, transduced, twitcher oligodendrocytes attained the normal branched process configuration, while untransduced cells show only abnormal morphology. Phenotype correction in mutant oligodendrocytes has also been observed after enzyme transfer. These studies indicate that GALC activity supplied to cultured oligodendrocytes from twitcher mice by different methods can correct the pathological phenotype of these cells.
INTRODUCTION
Krabbe disease or globoid cell leukodystrophy (GLD) is a lysosomal disorder resulting from the deficiency of galactocerebrosidase (GALC) activity (Wenger, 1997; Wenger et al., 2001) . This enzyme catalyzes the lysosomal hydrolysis of galactosylceramide (gal-cer) (Suzuki and Suzuki, 1970) and galactosylsphingosine (psychosine) (Miyatake and Suzuki, 1972) .
Galactosylceramide is an important component of the peripheral and central nervous system myelin and is a marker for myelin forming cells. Pathological evaluation of the nervous tissues reveals extensive demyelination, gliosis, and the characteristic globoid cells which contain undegraded galactosylceramide from the degenerating myelin. The pathogenesis of the disease is attributed to progressive accumulation of undegraded psychosine, a highly cytotoxic compound responsible for the rapid loss of oligodendrocytes (for review see Suzuki, 1998) . At this time the only treatment is bone marrow transplantation (BMT) that has been tried in some patients who do not yet have
